Alto Neuroscience
ANRO · NYSE
$24.41+$1.59 (+6.97%)TodayMarket closed ·
Prev close $22.82
EPS: actual vs estimate
Beat the estimate in 5 of the last 8 quarters, by 13.8% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$0.7492 | -$0.65 | +13.2% |
| Q1 FY26 | -$0.5473 | -$0.80 | −46.2% |
| Q4 FY25 | -$0.5414 | -$0.58 | −7.1% |
| Q3 FY25 | -$0.6811 | -$0.52 | +23.7% |
| Q2 FY25 | -$0.6253 | -$0.65 | −4.0% |
| Q1 FY25 | -$0.6202 | -$0.56 | +9.7% |
| Q4 FY24 | -$0.663 | -$0.56 | +15.5% |
| Q3 FY24 | -$0.6664 | -$0.62 | +7.0% |
Earnings calls
- ANRO - TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
- ANRO - 2024 Cantor Fitzgerald Global Healthcare Conference
- ANRO - Investor Day 2024
- ANRO - UBS Virtual CNS Day 2024
- ANRO - Jefferies 2024 Global Healthcare Conference
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.